Infections and Infectious Diseases

  • Home
  • Infections and Infectious Diseases
Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Condition:   Indolent Systemic Mastocytosis
Interventions:   Other: Placebo;   Biological: Sarilumab
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 11, 2018 / by / in
ED Patient’s Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing

Conditions:   Hepatitis C;   Viral Load Testing;   Point of Care
Intervention:   Diagnostic Test: Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid)
Sponsor:   Johns Hopkins University
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 10, 2018 / by / in
Tabelecleucel in Combination With Pembrolizumab in Subjects With EBV+ Nasopharyngeal Carcinoma (ATA129-NPC-202)

Conditions:   Nasopharyngeal Carcinoma;   Nasopharyngeal Neoplasms;   Epstein-Barr Virus Infections;   Epstein-Barr Viraemia
Interventions:   Biological: tabelecleucel;   Biological: pembrolizumab
Sponsors:   Atara Biotherapeutics;   Merck Sharp & Dohme Corp.
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 9, 2018 / by / in
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Conditions:   Non-hodgkin Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Biological: CD19.CAR-multiVST for Group A;   Biological: CD19.CAR-multiVST for Group B
Sponsors:   Baylor College of Medicine;   Texas Children’s Hospital;   The Methodist Hospital System;   Center for Cell and Gene Therapy, Baylor College of Medicine
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 8, 2018 / by / in
Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth

Conditions:   Reproductive Health;   Contraception;   Sexually Transmitted Diseases
Intervention:   Other: In the Know: sexual health education
Sponsors:   University of California, San Francisco;   Youth+Tech+Health;   Fresno Economic Opportunities Commission;   Department of Health and Human Services
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 7, 2018 / by / in
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age

Condition:   HIV Infections
Interventions:   Drug: Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Dispersible Tablets;   Drug: Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Immediate Release Tablets (Immediate release)
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   International Maternal Pediatric Adolescent AIDS Clinical Trials Network;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute of Mental Health (NIMH);   ViiV Healthcare Ltd.
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 6, 2018 / by / in
Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Conditions:   Staphylococcus Aureus Bacteremia;   Staphylococcus Aureus Endocarditis
Intervention:   Drug: Oritavancin Injection
Sponsor:   University of Pennsylvania
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 4, 2018 / by / in
Tranexamic Acid Per Inhalation for Treatment of Pulmonary Hemorrhage in Pediatric Patients

Conditions:   Pulmonary Hemorrhage;   MAPCA – Major Aortopulmonary Collateral Artery
Intervention:   Drug: Tranexamic Acid
Sponsor:   Baylor College of Medicine
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 2, 2018 / by / in
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Conditions:   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndromes;   Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions:   Procedure: Stem cell transplantation;   Drug: Itacitinib;   Other: Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT);   Other: Human Activity Profile
Sponsors:   Washington University School of Medicine;   Incyte Corporation
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 1, 2018 / by / in